Disclosure under SEBI Takeover Regulations

Sachin D. Patel Chayya, 67 Swastik Society, N.S. Road No.5, JVPD Scheme, Next to Joy Elegance Building, Vile Parle (West), Mumbai - 400056, Maharashtra. 1st July, 2026 Corporate Relationship Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Dalal Street, Mumbai- 400001 Bandra Kurla Complex, Scrip Code: 506879 Bandra (East), Mumbai- 400051 Symbol: GUJTHEM Dear Sir / Madam, Sub:- Inter-se transfer of Equity Shares between Promoters and Promoter group Reference: Disclosure pertaining to Regulation 10(5) of SEBI (SAST) Regulations, 2011 ("SEBI (SAST) Regulations") In compliance with the Regulation 10(5) of SEBI (SAST) Regulations, I, Sachin D. Patel, Promoter / belonging to the Promoter Group of Gujarat Themis Biosyn Limited (hereinafter referred as "the Company hereby wish to inform you that, I propose to acquire equity shares of the Company from Pharmaceutical Business Group (India) Limited, detailed in the attached disclosure. The above acquisition is inter-se transfer between Promoter / Promoter Group of the Company. Please find enclosed herewith the disclosure under Regulation 10(5) of SEBI (SAST) Regulations in the prescribed format to be given for the said acquisition of Equity Shares of the Company. You are requested to take the same on your record and oblige. Thanking you, Yours faithfully, Sachin D. Patel (Acquirer) Vineet Gawankar Company Secretary and Compliance Officer Gujarat Themis Biosyn Limited 69/C GIDC Industrial Estate, Vapi – 396 195, Dist. Valsad, Gujarat, India. Encl.: As above Sachin D. Patel Chayya, 67 Swastik Society, N.S. Road No.5, JVPD Scheme, Next to Joy Elegance Building, Vile Parle (West), Mumbai - 400056, Maharashtra. Format for Disclosures under Regulation 10(5) - Intimation to Stock Exchanges in respect of acquisition under Regulation 10(1)(a) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 1 Name of the Target Company (TC) Gujarat Themis Biosyn Limited 2 Name of the acquirer(s) Sachin D. Patel 3 Whether the acquirer(s) is/ are promoters of the TC Yes prior to the transaction. If not, nature of relationship or association with the TC or its promoters 4 Details of the proposed acquisition a. Name of the person(s) from whom shares are to Pharmaceutical Business Group be acquired (India) Limited b. Proposed date of acquisition 08.07.2026 to 14.07.2026 c. Number of shares to be acquired from each Up to 5,25,000 equity shares person mentioned in 4(a) above (proposed to acquire shares worth up to Rs.20 Crores) d. Total shares to be acquired as % of share Up to 0.50% capital of TC e. Price at which shares are proposed to be Rs. 395.75 per equity share acquired f. Rationale, if any, for the proposed transfer Inter se transfer among the Promoter and Promoter Group. 5 Relevant sub-clause of regulation 10(1)(a) under 10(1)(a)(ii) which the acquirer is exempted from making open offer 6 If, frequently traded, volume weighted average Rs. 376.60 per equity share market price for a period of 60 trading days preceding the date of issuance of this notice as traded on the stock exchange where the maximum volume of trading in the shares of the TC are recorded during such period. 7 If in-frequently traded, the price as determined in Not applicable terms of clause (e) of sub-regulation (2) of regulation 8. 8 Declaration by the acquirer, that the acquisition Yes, price would not be higher by more than 25% of the price computed in point 6 or point 7 as applicable. The Acquirer hereby declare that the acquisition price would not be higher by more than 25% of the price as determined in terms of clause (b) (c) & (d) of sub regulations (2) of the regulation 8 of the SEBI (SAST) Regulations, 2011 9 Declaration by the acquirer, that the transferor and Yes, transferee have complied (during 3 years prior to the date of proposed acquisition) / will comply with The Acquirer hereby declare that applicable disclosure requirements in Chapter V of both Transferor(s) and Sachin D. Patel Chayya, 67 Swastik Society, N.S. Road No.5, JVPD Scheme, Next to Joy Elegance Building, Vile Parle (West), Mumbai - 400056, Maharashtra. the Takeover Regulations, 2011 (corresponding Transferee(s) have complied provisions of the repealed Takeover Regulations with the applicable disclosure 1997) Requirements in Chapter V of The aforesaid disclosures made during previous 3 the SEBI (SAST) Regulations, years prior to the date of proposed acquisition to be 2011 furnished. 10 Declaration by the acquirer that all the conditions Yes, specified under regulation 10(1)(a) with respect to exemptions has been duly complied with. The Acquirer hereby declare that all the conditions specified under regulation 10(1)(a)(ii) with respect to exemptions has been duly complied with. 11 Shareholding details Before the proposed After the proposed transaction transaction No. of shares % wrt total No. of shares % wrt total /voting rights Share /voting rights Share capital of capital of TC TC a Acquirer(s) and PACs 24,97,200 2.29% 30,22,200 2.77% (other than sellers)(*) Dr. Sachin Patel b Seller (s) 5,12,40,000 47.02% 5,07,15,000 46.54% Themis Medicare Limited No. of shares mentioned above are proposed to acquire. Actual acquisition may be lesser than same. Note: • (*) Shareholding of each entity may be shown separately and then collectively in a group. • The above disclosure shall be signed by the acquirer mentioning date & place. In case, there is more than one acquirer, the report shall be signed either by all the persons or by a person duly authorized to do so on behalf of all the acquirers. Sachin D. Patel Acquirer Place: Mumbai Date:1st July 2026